Mabgeek Biotechnology
PrivateLast Round
IPO
Jul 14, 2025
Est. Valuation
$368.11M
Total Funding Raised
$53.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mabgeek Biotechnology operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a VC Round in July 2025.
Mabgeek Biotechnology is a biotechnology company that develops antibody-based therapeutics and provides related technical services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mabgeek Biotechnology Comparables
Compare Mabgeek Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Connect Biopharma Holdings Limited | 91% | |
| KeyMed Biosciences | 86% | |
| Qyuns Therapeutics Co Ltd | 86% |
For institutional investors. Book with your work email.
Mabgeek Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jul 14, 2025 | ||||
| VC Round | Jul 1, 2025 | ||||
| Series B | Aug 12, 2024 | ||||
| Series A | Jul 1, 2017 |
For institutional investors. Book with your work email.
Mabgeek Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hunan Tianrui Fengnian Private Equity Fund Management | Series B |
| China International Capital Corporation | IPO |
| New Horizon Capital | Series A |
| Qiming Venture Partners | Series A |
| Quan Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 52% MoM.
- Jul 14, 2025
Led by China International Capital Corporation
For institutional investors. Book with your work email.
Mabgeek Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mabgeek Biotechnology's valuation, stock price, and market status.
Is Mabgeek Biotechnology a public or private company?
Mabgeek Biotechnology is a private company.
What is the current stock price of Mabgeek Biotechnology?
Mabgeek Biotechnology is a private company, so its shares have no public market price. Caplight tracks Mabgeek Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mabgeek Biotechnology worth (valuation)?
Mabgeek Biotechnology's valuation is estimated at $368.1M based on funding round data.
Can I buy Mabgeek Biotechnology stock?
Mabgeek Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mabgeek Biotechnology's last funding round?
Mabgeek Biotechnology's most recent funding round was IPO on July 14, 2025.
Who are the main investors in Mabgeek Biotechnology?
Key investors in Mabgeek Biotechnology include China International Capital Corporation.
Will Mabgeek Biotechnology IPO soon?
No public IPO plans have been announced for Mabgeek Biotechnology.
How can I track Mabgeek Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Mabgeek Biotechnology's shares on secondary markets.